HEPZATO KIT Trademark

Trademark Overview


On Tuesday, September 9, 2025, a trademark application was filed for HEPZATO KIT with the United States Patent and Trademark Office. The USPTO has given the HEPZATO KIT trademark a serial number of 99382166. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, February 3, 2026. This trademark is owned by Delcath Systems, Inc.. The HEPZATO KIT trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Personal, and Legal & Social Services categories with the following description:

Drug delivery systems; double balloon catheter system comprised primarily of catheters

Providing personal support services for patients and families of patients with liver disorders, namely, financial counseling, help with medical forms and care coordination

Pharmaceutical products for the treatment of cancer; drug delivery systems, namely, drug delivery agents consisting of compounds that facilitate delivery of a range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems comprising melphalan hydrochloride for injection for administering high dose chemotherapy to the liver
hepzato kit

General Information


Serial Number99382166
Word MarkHEPZATO KIT
Filing DateTuesday, September 9, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, February 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDrug delivery systems; double balloon catheter system comprised primarily of catheters
Goods and ServicesProviding personal support services for patients and families of patients with liver disorders, namely, financial counseling, help with medical forms and care coordination
Goods and ServicesPharmaceutical products for the treatment of cancer; drug delivery systems, namely, drug delivery agents consisting of compounds that facilitate delivery of a range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems comprising melphalan hydrochloride for injection for administering high dose chemotherapy to the liver

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 9, 2025
Primary Code005
First Use Anywhere DateWednesday, August 16, 2023
First Use In Commerce DateWednesday, August 16, 2023

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, September 9, 2025
Primary Code010
First Use Anywhere DateWednesday, August 16, 2023
First Use In Commerce DateWednesday, August 16, 2023

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 9, 2025
Primary Code045
First Use Anywhere DateSaturday, January 27, 2024
First Use In Commerce DateSaturday, January 27, 2024

Trademark Owner History


Party NameDelcath Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressQUEENSBURY, NY 12804

Trademark Events


Event DateEvent Description
Tuesday, September 9, 2025NEW APPLICATION ENTERED
Tuesday, September 9, 2025APPLICATION FILING RECEIPT MAILED
Thursday, January 29, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 30, 2026ASSIGNED TO EXAMINER
Tuesday, February 3, 2026NON-FINAL ACTION WRITTEN
Tuesday, February 3, 2026NON-FINAL ACTION E-MAILED
Tuesday, February 3, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED